Alliance Member News
Alliance Members don’t just read the news ... they make the news. To check out our “Members News” from prior years, click the list below:
Delphinus Receives FDA Approval
October 12, 2021
Delphinus Medical Technologies announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) of its SoftVue™ 3D Whole Breast Ultrasound Tomography System (SoftVue™) for use as an adjunct to digital mammography in the screening of asymptomatic women with dense breast tissue. Alliance member Mark Forchette is the President and CEO at Delphinus.
Read More
ALX Oncology Acquires ScalmiBio
October 07, 2021
ALX Oncology has strengthened its immuno-oncology pipeline with the acquisition of ScalmiBio. ALX is led by Alliance member Jaume Pons.
Read More
Xantrion Named to the 100 Largest Bay Area Women-Owned Businesses List
September 14, 2021
Congratulations to Alliance member Anne Bisagno and Xantrion on being recognized as one of the San Francisco Business Times "Largest Women-Owned Businesses" for the fourteenth consecutive year.
Read More
Versatile Secures $80M Series B
September 14, 2021
Versatile secures $80M Series B to further its mission to drive predictive, controllable processes in construction. Alliance member Meirav Oren is the CEO & Co-Founder of Versatile.
Read More
Copado DevOps Raises $140M in Series C Financing
September 13, 2021
Copado, a leading DevOps platform powering some of the world's largest digital transformations, announced it has raised $140 million in Series C financing, bringing the total funds invested in the company to $257 million. Alliance member Ted Elliott is the CEO of Copado.
Read More
Proximie Partners with Teladoc Health to Connect Operating Rooms Globally
September 09, 2021
Proximie, a health technology platform focused on digitizing operating and diagnostic rooms, announced an integration with Teladoc Health's Solo platform for hospitals and health systems. Proximie is led by Alliance member Nadine Hachach-Haram.
Read More
One Medical Completes Acquisition of Iora Health
September 01, 2021
One Medical, a leading human-centered and technology-powered national primary care organization, announced it has completed the acquisition of Iora Health. Alliance member Amir Dan Rubin is the Chair & CEO of One Medical.
Read More
Natera Announces the Validation and Launch of the Prospera Heart Transplant Assessment Test
August 31, 2021
Natera, a leader in transforming care through genetic and cell-free DNA (cfDNA) testing, announced the validation and clinical availability of its Prospera Heart transplant assessment test for heart transplant recipients. Alliance member Bernie Tobin, is the General Manager of Natera's organ health division.
Read More
Xicato Wins Two Coveted Sapphire Awards
August 25, 2021
Xicato, the leading provider of smart building wireless controls and highest quality spot and linear lighting, is proud to announce that two of Xicato's lighting and controls solutions have won the highly coveted Sapphire Awards by LEDs Magazine. The Sapphire Awards is an esteemed awards program in the LED and solid-state lighting (SSL) sectors honoring innovation in enabling technologies and elegance-of-design in finished lighting products. Alliance member Amir Zoufonoun is the CEO of Xicato.
Read More
Cork Supply USA Named to the List of the “Best Places to Work in the North Bay”
August 23, 2021
Congratulations to Cork Supply USA, led by Alliance member Peter Hladun, on being named to the North Bay Business Journal's list of the "Best Places to Work in the North Bay!"
Read More
Apeel Bites into Another $250M Funding Round
August 18, 2021
Apeel Sciences, a food system innovation company, added $250 million in Series E funding, giving it a valuation of $2 billion, to speed up the availability of its longer-lasting produce in the U.S. (where approximately 40% of food is wasted), the U.K. and Europe. Alliance member Brian Sohmers is the VP of Product for Apeel.
Read More
Sutro Biopharma Ovarian Cancer Drug Gets FDA’s Fast Track Tag
August 18, 2021
Sutro Biopharma announced that the FDA has granted Fast Track designation to its drug STRO-002, a folate receptor (“FR”) alpha-targeting antibody-drug conjugate (“ADC”), to treat advanced ovarian cancer in patients who have received one to three prior lines of systemic therapy. Sutro Biopharma is led by Alliance member Bill Newell.
Read More
8 Alliance Members Make the INC 5000 Fastest Growing List
August 17, 2021
Eight companies, led by Alliance Members, were named to the 2021 INC 5000 list of the Fastest Growing Private Companies in the U.S.
Read More
Rubrik Announces Strategic Agreement with Microsoft
August 17, 2021
Rubrik announced a strategic agreement with Microsoft to mitigate ransomware threats and tightly integrate cloud services. Alliance member Anneka Gupta is the Chief Product Officer for Rubrik.
Read More
World’s First Surgery Using Virtual Incision’s MIRA Miniature Robotic System
August 16, 2021
Virtual Incision Corporation, a medical device company pioneering first-of-its-kind miniaturized robots for laparoscopic surgery, announced that the world’s first surgery using the MIRA™ (“miniaturized in vivo robotic assistant”) Surgical Platform has been successfully performed by Michael A. Jobst, M.D., at Bryan Medical Center in Lincoln, Nebraska. Virtual Incision is led by Alliance member John Murphy.
Read More
Luke Haverhals Named to “Researcher to Know in 2021” List
August 16, 2021
Congratulations to Alliance member, Dr. Luke Haverhals, who has been named to the Illinois Science and Technology Coalition's "Researcher to Know in 2021" list.
Read More
Eyevensys Raises $12M in a Series B Plus Funding Round
August 04, 2021
Eyevensys, a privately held, clinical-stage biotechnology company developing non-viral gene therapies for ophthalmic diseases, announced it has raised $12M in a Series B Plus funding round. Eyevensys is led by Alliance member Patricia Zilliox.
Read More
Industrial cybersecurity firm Nozomi Networks raises $100M
August 02, 2021
Industrial cybersecurity firm Nozomi Networks announced it has raised $100 million in new funding to help accelerate the company’s growth. Alliance member Edgard Capdevielle is the CEO of Nozomi.
Read More
Caribou Biosciences Announces Pricing of Upsized Initial Public Offering
July 22, 2021
Caribou Biosciences, Inc., a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today the pricing of its upsized initial public offering of 19,000,000 shares of common stock at a public offering price of $16.00 per share. Alliance member Rachel Haurwitz is the CEO of Caribou.
Read More
Novome Announces Phase 1 Trial of GEMM Cell Therapy
July 03, 2021
Novome Biotechnologies has announced the beginning of its phase 1 trial evaluating NOV-001, a once-daily Genetically Engineered Microbial Medicine for the treatment of enteric hyperoxaluria. Alliance member Blake Wise is the CEO of Novome.
Read MoreAbout
The Alliance of Chief Executives is an active community of business leaders that focuses on deep strategic exchanges, challenging existing assumptions and generating fresh ideas.
Contact Us
Alliance of Chief Executives, LLC
2185 N. California Blvd.,
Suite 590
Walnut Creek, CA 94596
- 925-942-2400 Office
- 925-956-4424 Fax
- Email: info@allianceofCEOs.com
Newsletter
Subscribe to our newsletter and stay up to date with the latest Alliance news!
About
The Alliance of Chief Executives is an active community of business leaders that focuses on deep strategic exchanges, challenging existing assumptions and generating fresh ideas.
Newsletter
Subscribe to our newsletter and stay up to date with the latest Alliance news!
Member Resources
Contact Us
2185 N. California Blvd., Suite 590
Walnut Creek, CA 94596
925-942-2400 Office
925-956-4424 Fax
Email: info@allianceofCEOs.com
2021 © Alliance of Chief Executives, LLC
